Cargando…

Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion

Oral ingestion of carbohydrate triggers glucagon-like peptide 1 (GLP1) secretion, but the molecular mechanism remains elusive. By measuring GLP1 concentrations in murine portal vein, we found that the ATP-sensitive K(+) (K(ATP)) channel is not essential for glucose-induced GLP1 secretion from entero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Eun Young, Kaneko, Shuji, Jutabha, Promsuk, Zhang, Xilin, Seino, Susumu, Jomori, Takahito, Anzai, Naohiko, Miki, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324305/ https://www.ncbi.nlm.nih.gov/pubmed/25486965 http://dx.doi.org/10.1530/JOE-14-0555

Ejemplares similares

Molecular Mechanism of Ochratoxin A Transport in the Kidney
por: Anzai, Naohiko, et al.
Publicado: (2010)

Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin
por: Ouchi, Motoshi, et al.
Publicado: (2018)

Contribution of Rare Variants of the SLC22A12 Gene to the Missing Heritability of Serum Urate Levels
por: Misawa, Kazuharu, et al.
Publicado: (2020)

Effects of Flavanols on Enteroendocrine Secretion
por: Grau-Bové, Carme, et al.
Publicado: (2020)

Clinical and Functional Characterization of URAT1 Variants
por: Tasic, Velibor, et al.
Publicado: (2011)

Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies
por: Wempe, Michael F, et al.
Publicado: (2012)

Galanin inhibits GLP‐1 and GIP secretion via the GAL(1) receptor in enteroendocrine L and K cells
por: Psichas, Arianna, et al.
Publicado: (2016)

Olfactory Receptor OR51E1 Mediates GLP-1 Secretion in Human and Rodent Enteroendocrine L Cells
por: Han, Ye Eon, et al.
Publicado: (2018)

The alpha-glucosidase inhibitor miglitol increases hepatic CYP7A1 activity in association with altered short-chain fatty acid production in the gut of obese diabetic mice
por: Hamada, Yoji, et al.
Publicado: (2020)

Switching α-Glucosidase Inhibitors to Miglitol Reduced Glucose Fluctuations and Circulating Cardiovascular Disease Risk Factors in Type 2 Diabetic Japanese Patients
por: Hariya, Natsuyo, et al.
Publicado: (2014)

Hesperetin Stimulates Cholecystokinin Secretion in Enteroendocrine STC-1 Cells
por: Kim, Hye Young, et al.
Publicado: (2013)

Circadian hormone secretion of enteroendocrine cells: implication on pregnancy status
por: Homeida, Abdelgadir M., et al.
Publicado: (2023)

Type 2 diabetes is associated with impaired jejunal enteroendocrine GLP-1 cell lineage in human obesity
por: Osinski, Céline, et al.
Publicado: (2020)

Salmonella Infection Causes Hyperglycemia for Decreased GLP-1 Content by Enteroendocrine L Cells Pyroptosis in Pigs
por: Zong, Yibo, et al.
Publicado: (2022)

Role of Intestinal Bitter Sensing in Enteroendocrine Hormone Secretion and Metabolic Control
por: Xie, Cong, et al.
Publicado: (2018)

Enteroendocrine Hormone Secretion and Metabolic Control: Importance of the Region of the Gut Stimulation
por: Xie, Cong, et al.
Publicado: (2020)

Stability-Indicating RP-HPLC Method for Estimation of Miglitol in Bulk and Tablets
por: Shrivastava, B., et al.
Publicado: (2010)

Effect of the Addition of Sitagliptin and Miglitol on Insulin-Treated Type 2 Diabetes
por: Kishimoto, Miyako, et al.
Publicado: (2012)

Combination therapy of miglitol and insulin in type 1 diabetes mellitus patients
por: Kubo, Sayaka, et al.
Publicado: (2010)

Review: Miglitol has potential as a therapeutic drug against obesity
por: Sugimoto, Satoru, et al.
Publicado: (2015)

Acute selective bioactivity of grape seed proanthocyanidins on enteroendocrine secretions in the gastrointestinal tract
por: Casanova-Martí, Àngela, et al.
Publicado: (2017)

Incretin Kinetics Before and After Miglitol in Japanese Patients With Late Dumping Syndrome
por: Amagai, Mari, et al.
Publicado: (2017)

Bacterial Metabolite Indole Modulates Incretin Secretion from Intestinal Enteroendocrine L Cells
por: Chimerel, Catalin, et al.
Publicado: (2014)

Role of enteroendocrine L‐cells in arginine vasopressin‐mediated inhibition of colonic anion secretion
por: Pais, Ramona, et al.
Publicado: (2016)

Kinetic Determination of Acarbose and Miglitol in Bulk and Pharmaceutical Formulations Using Alkaline Potassium Permanganate
por: Ibrahim, F. A., et al.
Publicado: (2007)

α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study
por: Shimabukuro, Michio, et al.
Publicado: (2017)

Gpr40 Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin Secretion
por: Edfalk, Sara, et al.
Publicado: (2008)

Activation of Enteroendocrine Membrane Progesterone Receptors Promotes Incretin Secretion and Improves Glucose Tolerance in Mice
por: Flock, Grace B., et al.
Publicado: (2013)

Glucolipotoxicity and GLP-1 secretion
por: Hong, Jung-Hee, et al.
Publicado: (2021)

Pharmacology and physiology of gastrointestinal enteroendocrine cells
por: Mace, O J, et al.
Publicado: (2015)

Involvement of the enteroendocrine system in intestinal obstruction
por: Ballouhey, Quentin, et al.
Publicado: (2017)

Enteroendocrine Dysfunction in Two Saudi Sisters
por: Ahmed, Amna Basheer M., et al.
Publicado: (2021)

Tau expression and phosphorylation in enteroendocrine cells
por: Chapelet, Guillaume, et al.
Publicado: (2023)

Development and Validation of Miglitol and Its Impurities by RP-HPLC and Characterization Using Mass Spectrometry Techniques
por: Balakumaran, Kesavan, et al.
Publicado: (2016)

Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model
por: Kishida, Yumi, et al.
Publicado: (2017)

SGLT2is vs. GLP1RAs Reduce Cardiovascular and All-Cause Mortality
por: Qiu, Mei, et al.
Publicado: (2021)

SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain
por: Rolek, Bartosz, et al.
Publicado: (2023)

Antihyperglycemic Effects of Salvia polystachya Cav. and Its Terpenoids: α-Glucosidase and SGLT1 Inhibitors
por: Ortega, Rocio, et al.
Publicado: (2022)

Serotonin-secreting enteroendocrine cells respond via diverse mechanisms to acute and chronic changes in glucose availability
por: Zelkas, Leah, et al.
Publicado: (2015)

Intermittent Hypoxia Up-Regulates Gene Expressions of Peptide YY (PYY), Glucagon-like Peptide-1 (GLP-1), and Neurotensin (NTS) in Enteroendocrine Cells
por: Shobatake, Ryogo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2k8deo06l23hcod9pjc4mn441g